Course Provider
Learning Objectives
Define Alpha-1 Antitrypsin Deficiency, including its genetic components and phenotypes.
Identify the three primary systems affected by Alpha-1 Antitrypsin Deficiency.
Distinguish the clinical manifestations of Alpha-1 Antitrypsin Deficiency in lung and liver disease.
Identify current augmentation therapy options.